Sanofi Pasteur MSD Welcomes the Publication of a Special Issue on the Economic Value of Vaccination

Lyon, France (ots/PRNewswire) -

A relevant and comprehensive approach on the benefits of vaccines
on healthcare

systems sustainability and economic growth

Sanofi Pasteur MSD is proud to announce the publication of a
supplement dedicated to the economic value of vaccination in the
Journal of Market Access and Health Policy. The series of 7 articles
has been developed by Sanofi Pasteur MSD and a group of 11 public
health and economics experts, from 8 EU countries.

To view the Multimedia News Release, please click:

http://www.multivu.com/players/uk/7573951-sanofi-pasteur-msd-vacci
nation

"Prevention is one of the most appropriate responses to Europe's
health and growth challenges" said Andrea Rappagliosi, Vice President
Market Access, Health Policy and Medical Affairs of Sanofi Pasteur
MSD. "Vaccination helps tackle resurging and emerging infectious
diseases and improve the health of an ageing population. This
publication provides further evidence of Sanofi Pasteur MSD's leading
position in Europe as a health partner of choice," he concluded.

Vaccination represents today only 0.3% of healthcare expenditure
in an EU country like France. Although a minor fraction of the
healthcare budget is allocated to vaccination programs in Europe,
these have a central role in prevention policies and are recognized
as one of the most cost-effective public health interventions. Beyond
acknowledged impact on public health, this series of articles depicts
impact of vaccination on economic growth, sustainability and
efficiency of healthcare systems. It emphasizes several invisible
gains from vaccination that are traditionally ignored in economic
analyses.

"This series of articles constitutes a comprehensive source of
information on vaccination' benefits and depicts the problem from
different angles and perspectives. They help to realize the broad
spectrum of benefits that add to health, economic and societal gains
of immunization" said Prof. Mondher Toumi and Prof. Walter Ricciardi.
"Bringing this message to the patients and authorities and increasing
awareness of true value of vaccination is of great importance
nowadays. Promoting and strengthening the role of vaccines is in line
with recently published document by Council of the European Union,"
they added.

Exclusively dedicated to vaccines in Europe, Sanofi Pasteur MSD is
a committed public health partner, fully focused on Europe's future,
people and healthcare systems. This approach aims to demonstrate that
vaccines have relevance for wider economic planning and require
adequate value recognition to ensure quick population access and wide
acceptability.

Video:
http://www.multivu.com/players/uk/7573951-sanofi-pasteur-msd-vaccination

ots Originaltext: Sanofi Pasteur MSD GmbH
Im Internet recherchierbar: http://www.presseportal.de

Contact:
Contact
Sanofi Pasteur MSD
Sylvia Martin-Jarrand
Tel : +33-4-37-28-40-55
smartin-jarrand@spmsd.com
Sanofi Pasteur MSD
Loïc Frerejouand
lfrerejouand@spmsd.com